Corrigendum: MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool (Nature (2014) 508 (215-221) DOI: 10.1038/nature13181);MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool

Nature

Volumn 508, Issue 7495, 2014, Pages 215-221

  Gad, Helge ^a   Koolmeister, Tobias ^a   Jemth, Ann Sofie ^a   Eshtad, Saeed ^a   Jacques, Sylvain A ^a   Ström, Cecilia E ^a   Svensson, Linda M ^b   Schultz, Niklas ^a   Lundbäck, Thomas ^a   Einarsdottir, Berglind Osk ^c   Saleh, Aljona ^b   Göktürk, Camilla ^a   Baranczewski, Pawel ^a,d   Svensson, Richard ^a,d   Berntsson, Ronnie P A ^b   Gustafsson, Robert ^b   Strömberg, Kia ^a   Sanjiv, Kumar ^a   Jacques Cordonnier, Marie Caroline ^a   Desroses, Matthieu ^a   Gustavsson, Anna Lena ^a   Olofsson, Roger ^c   Johansson, Fredrik ^b   Homan, Evert J ^a   Loseva, Olga ^a   Bräutigam, Lars ^a   Johansson, Lars ^a   Höglund, Andreas ^a   Hagenkort, Anna ^a   Pham, Therese ^a   Altun, Mikael ^a   Gaugaz, Fabienne Z ^a,d   Vikingsson, Svante ^a,e   Evers, Bastiaan ^a,f   Henriksson, Martin ^a   Vallin, Karl S A ^a   Wallner, Olov A ^a   Hammarström, Lars G J ^a   Wiita, Elisee ^a   Almlöf, Ingrid ^a   Kalderén, Christina ^a   Axelsson, Hanna ^a   Djureinovic, Tatjana ^b,d   Puigvert, Jordi Carreras ^a   Häggblad, Maria ^b   Jeppsson, Fredrik ^a   Martens, Ulf ^b   Lundin, Cecilia ^a   Lundgren, Bo ^b   Granelli, Ingrid ^b   Jensen, Annika Jenmalm ^a   Artursson, Per ^a,d   Nilsson, Jonas A ^c   Stenmark, Pål ^b   Scobie, Martin ^a   Berglund, Ulrika Warpman ^a   Helleday, Thomas ^a   more..

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e LINKÖPING UNIVERSITY   (Sweden)

^f NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYNUCLEOSIDE TRIPHOSPHATE; MTH1 PROTEIN; MTH1 PROTEIN INHIBITOR; NUCLEOSIDE DERIVATIVE; PROTEIN; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; 8 OXODEOXYGUANOSINE TRIPHOSPHATE; 8 OXODGTPASE; 8-OXODEOXYGUANOSINE TRIPHOSPHATE; 8-OXODGTPASE; DEOXYGUANOSINE PHOSPHATE; ENZYME INHIBITOR; INORGANIC PYROPHOSPHATASE; NUCLEOTIDE; NUDIX HYDROLASES; PHOSPHATASE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PYRIMIDINE DERIVATIVE; TH287 COMPOUND; TH588 COMPOUND;

CANCER; DNA; INHIBITION; PROTEIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CELL DEATH; CONTROLLED STUDY; DISEASE ERADICATION; DNA DAMAGE; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MALE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; TANDEM MASS SPECTROMETRY; ANIMAL; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; CRYSTALLIZATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVE SITE; METABOLISM; MOLECULARLY TARGETED THERAPY; MOUSE; NEOPLASM; OXIDATION REDUCTION REACTION; PATHOLOGY; REPRODUCIBILITY;

ANIMALS; CATALYTIC DOMAIN; CELL DEATH; CELL SURVIVAL; CRYSTALLIZATION; DEOXYGUANINE NUCLEOTIDES; DNA DAMAGE; DNA REPAIR ENZYMES; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; MICE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR TARGETED THERAPY; NEOPLASMS; NUCLEOTIDES; OXIDATION-REDUCTION; PHOSPHORIC MONOESTER HYDROLASES; PYRIMIDINES; PYROPHOSPHATASES; REPRODUCIBILITY OF RESULTS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84899619506     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature22083     Document Type: Erratum

References (46)

1. Druker, B. J. et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nature Med. 2, 561-566 (1996).
2. Bryant, H. E. et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose)polymerase. Nature 434, 913-917 (2005).
3. Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917-921 (2005).
4. Alexandrov, L. B. et al. Signatures ofmutational processes in humancancer. Nature 500, 415-421 (2013).
5. Zhang, Y. et al. Redox control of the survival of healthy and diseased cells. Antioxid. Redox Signal. 15, 2867-2908 (2011).
6. Luo, M., He, H., Kelley, M. R. & Georgiadis, M. M. Redox regulation of DNA repair: implications for human health and cancer therapeutic development. Antioxid. Redox Signal. 12, 1247-1269 (2010).
7. Topal, M. D.&Baker, M. S.DNAprecursor pool: a significant target for N-methyl-Nnitrosourea inC3H/10T1/2 clone 8 cells. Proc. Natl Acad. Sci. USA79, 2211-2215 (1982).
8. Sakumi, K. et al. Cloning and expression of cDNA for a human enzyme that hydrolyzes 8-oxo-dGTP, a mutagenic substrate for DNA synthesis. J. Biol. Chem. 268, 23524-23530 (1993).
9. Oka, S. et al. Two distinct pathways of cell death triggered by oxidative damage to nuclear and mitochondrial DNAs. EMBO J. 27, 421-432 (2008).
10. Ichikawa, J. et al. Oxidation of mitochondrial deoxynucleotide pools by exposure to sodium nitroprusside induces cell death. DNA Repair (Amst.) 7, 418-430 (2008).
11. Russo, M. T. et al. The oxidized deoxynucleoside triphosphate pool is a significant contributor to genetic instability in mismatch repair-deficient cells. Mol. Cell. Biol. 24, 465-474 (2004).
12. Rai, P. et al. Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence. Oncogene 30, 1489-1496 (2011).
13. Tsuzuki, T., Egashira, A. & Kura, S. Analysis of MTH1 gene function in mice with targeted mutagenesis. Mutat. Res. 477, 71-78 (2001).
14. Schultz, L. B., Chehab, N. H., Malikzay, A.& Halazonetis, T. D. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J. Cell Biol. 151, 1381-1390 (2000).
15. European StandardsCommittee onOxidativeDNADamage.Measurement ofDNA oxidation in human cells by chromatographic and enzymic methods. Free Radic. Biol. Med. 34, 1089-1099 (2003).
16. Yoshimura, D. et al. An oxidized purine nucleoside triphosphatase, MTH1, suppresses cell death caused by oxidative stress. J. Biol. Chem. 278, 37965-37973 (2003).
17. Narita, M. et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703-716 (2003).
18. Martinez Molina, D. et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341, 84-87 (2013).
19. Svensson, L. M. et al. Crystal structure of human MTH1 and the 8-oxo-dGMP product complex. FEBS Lett. 585, 2617-2621 (2011).
20. Ushijima, Y. et al. A functional analysis of the DNA glycosylase activity of mouse MUTYH protein excising 2-hydroxyadenine opposite guanine in DNA. Nucleic Acids Res. 33, 672-682 (2005).
21. German, P. et al. Activation of cellular signaling by 8-oxoguanine DNA glycosylase-1-initiatedDNAbase excision repair. DNA Repair (Amst.) 12, 856-863 (2013).
22. Hahn, W. C. et al. Creation of human tumour cells with defined genetic elements. Nature 400, 464-468 (1999).
23. McLennan, A. G. Substrate ambiguity among the nudix hydrolases: biologically significant, evolutionary remnant, or both? Cell. Mol. Life Sci. 70, 373-385 (2013).
24. Maki, H. & Sekiguchi, M. MutT protein specifically hydrolyses a potent mutagenic substrate for DNA synthesis. Nature 355, 273-275 (1992).
25. Fujikawa, K. et al. The oxidized forms of dATP are substrates for the human MutT homologue, the hMTH1 protein. J. Biol. Chem. 274, 18201-18205 (1999).
26. Speina, E. et al. Contribution of hMTH1 to the maintenance of 8-oxoguanine levels in lungDNAofnon-small-cell lungcancerpatients. J.Natl Cancer Inst. 97, 384-395 (2005).
27. Guo, Z., Kozlov, S., Lavin, M. F., Person, M. D. & Paull, T. T. ATM activation by oxidative stress. Science 330, 517-521 (2010).
28. Huber, K. V. M. et al. Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy. Nature http://dx.doi.org/10.1038/nature13194 (this issue).
29. De Luca, G. et al. Prolonged lifespan with enhanced exploratory behavior in mice overexpressing the oxidized nucleoside triphosphatase hMTH1. Aging Cell 12, 695-705 (2013).
30. De Luca, G. et al. A role for oxidized DNA precursors in Huntington's disease-like striatal neurodegeneration. PLoS Genet. 4, e1000266 (2008).
31. Sakumi, K. et al. Ogg1 knockout-associated lung tumorigenesis and its suppression by Mth1 gene disruption. Cancer Res. 63, 902-905 (2003).
32. Mohindra, A. et al. Defects in homologous recombination repair in mismatchrepair-deficient tumour cell lines. Hum. Mol. Genet. 11, 2189-2200 (2002).
33. Rai, P. et al. Continuous elimination of oxidized nucleotides is necessary to prevent rapid onset of cellular senescence. Proc. Natl Acad. Sci. USA 106, 169-174 (2009).
34. Herold, M. J., van den Brandt, J., Seibler, J. & Reichardt, H. M. Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats. Proc. Natl Acad. Sci. USA 105, 18507-18512 (2008).
35. O'Brien, J., Wilson, I., Orton, T. & Pognan, F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment ofmammalian cell cytotoxicity. Eur. J. Biochem. 267, 5421-5426 (2000).
36. Struthers, L., Patel, R., Clark, J. & Thomas, S. Direct detection of 8-oxodeoxyguanosine and 8-oxoguanine by avidin and its analogues. Anal. Biochem. 255, 20-31 (1998).
37. Dalle-Donne, I., Rossi, R., Giustarini, D., Milzani, A. & Colombo, R. Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 329, 23-38 (2003).
38. Baykov, A. A., Evtushenko, O. A. & Avaeva, S. M. A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay. Anal. Biochem. 171, 266-270 (1988).
39. Britsun, V.M.&Maiboroda,E. I.Cyclocondensations of 3-(R2-amino)-3-methylthio-1-R1-propenones with 2-aminoazoles. Ukr. Khim. Zh. 74, 126-128 (2008).
40. Kabsch, W. Xds. Acta Crystallogr. D 66, 125-132 (2010).
41. Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53, 240-255 (1997).
42. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126-2132 (2004).
43. Waters, N. J., Jones, R., Williams, G. & Sohal, B. Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding. J. Pharm. Sci. 97, 4586-4595 (2008).
44. Houston, J. B. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem. Pharmacol. 47, 1469-1479 (1994).
45. Baranczewski, P. et al. Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development. Pharmacol. Rep. 58, 453-472 (2006).
46. Hubatsch, I., Ragnarsson, E. G. & Artursson, P. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nature Protocols 2, 2111-2119 (2007).